Role of ions in Prolactin release .
To study the ro le of ions in th e release of Prolactin (PRL ) , several experim ents were performed uti l i zing disper sed pituitary cells obtained from adul t , femal e Sprague-Dawley rats. All tests were done after a cul t ur e period of 5 days in multiwell Petri pla t es at 3 x 10 5 cell s per well . Culture medium was Dulbecco' s modified Eagle's medium (DMEM) supplemented with 10% horse serum, 2.5% fetal calf ser um , non-essential amino-acids and antibiotics. PRL secretion was messured by specific RIA after 4 h of test incubation in various media at 37 0 in a CO 2/air incubator. Basal PRL secretion in DMEM (154±12 ng/ml) was drastically reduced in a hypoosmolsr , sodium deprived medium (48±4 ng/ml) , remained low when NaCI ws s rep laced by isoosmolar concentrat ions of gl ucose (33±2 ng/ml ), and was r estored by t he addition of either sodium or choline 110 mH . When DA 10-llMwas added to the medium wit h sodium, an 83% increment of PRL secretion was observed, whi le the neurotransmitter was comp l etely inactive in abse nce of NaCI . DA 5 x 10-6M strongly inh ibited PRL releas e in the presence of sodi um but was inactive either in the absence of the ion or when the ion channel was blo cked by tetrodotoxin (TTX) . Baseline and DA-stimulated PRL release were al so strongly inh ib ited by the add i t i on to the medium of eit her Co++ (a calcium channel blocker ) or TTX . These r esults indicate th at a normal ionic charge in the medium is essent i al f or baseline PRL secretion, while both sodium and calcium ion s The efficacy of Tr. ll. in the treatment of C.D. i n children and adolescents haa not been assessed . We treated 8 patients (7-6/12-18-9/1 2 yrs old ) wi t h C.D. by Tr .ll . (followup 8-72 months postoperatively). Growth failure and weight gain were th e first signs of C.D.; pubertal delay, virilization and fatigability were variable features. Preoperative evaluation showed elevated urinary free cortiaol and no diurnal variation in plasma cortisol or ACTH values; high dose dexamethasone therapy suppressed excretion of urinary free cortisol . Two of 8 patients lacked definite radiographic evidence of a pituitary adenoma. Transpheno idal exploration revealed 1-4 mm adenomas in 7 of 8 patients ; no definite adenoma was noted in t he 8t h patient i n spite of CT scan evidence of adenoma . Post opera t ive compl ica t io ns were limited to t ransient di abe t es insipidus . The 7 treated patients had low cortisol and ACTH secre tion pos toperatively and required replacem ent glucocorticoid therapy fo r 6-1 2 montha. Weight loss, gr owth and pubertal progression without recurrence o f C.D. were noted i n 6 patients with long term fol l owup. Our experience indicatea that ACTH se creti ng microadenomaa are t he principal caus e of C.D. in chi l dhood and adolescence and suggea ts that transphenoidal microadenectomy is th e initial treatment of choice for Cuahing's disease in young patients. 
Idiopathic 01 is assoc iated, by definit ion, with no obvious organic lesion. Despite negotive clinical ond neuroradiologicol investigotions , the question remains of the tumoral orig in of the disease, main ly if a nterior pituitary dysfunction is demonstrated . The purpose of t his st udy was to evaluate the course and si~nificance of th i s association. 26 patients (6 familial) were investigated, with a followup of 4-20 yrs (x: 12.5 yrs) after onset of polyuria. Pneumoencephalography (n: 27) ond/or CT scan (n= 11) were normol.
GH defic iency was present in 10/26 cases. Recovery, not related to puberty in all cases, was observed in 5 patients . TSH response to TRF (n= 17) was deficient (n: 3) or of the hypothalam ic type (n: 4). Puberty was normal i n 17 coses , and abnormal in 2 cases (respectively precoc ious and slowly progressing). GH deficiency was isolated in 5 cases or assoc iated with ACTH +TSH (n: 1), TSH (n: 1), ACTH (n : 3) abnormalities.
In conclusion : long term observation is necessary to ascerta~n the d~agnosis of i di opa t hi c 01. Ante rior pituita ry deficiency may be assoc iated, wi t hout any evidence of tumor. GH def i ciency may be transient. These f indings suggest that hypothalomic disturbances leading to idiopathic 01 involve more that the hypothalamic posterior pituitary system itself. In a subseauent study on similar patients (n=7,age 10-19 years) IlGIl (2IU,.m2) was injected s ;c, in the evenin:J.1lGIl concentration peaked at 5 hours (mean l7 ,range 7-28 n,/ml) am returned to baseline 14 hours after injection.'Ihe results indicate that absorption fran an Lm , depot is far too sh::lrt to give a P'Jysiological diurnal profile of IlGIl in plasma -even by da ily acin1nistration. lb!IeITer, daily s ,c, injecti on will,if given in the evenin:J,imitate ooIIllal oocturnal IlGIl profile.
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Dept. of Pediatrics, University of Zurich, Switzerland ·A-type· isolated growth honnane deficiency (IGHD). In 1970, we p..sented the ·A-type" of outooomol receuive IGHD characterized by early and severe grawth retordation, typical foce with vaulted forehead, a strong metabolic and grewth ..spanse to exogenous hGH, and a tendency to fonn high GH ant ibodies which abolish this efFect.
Recent events prompt us to report on these pat ients again:
l) Philipps et 01 (abstr.Ped.Res. 1981) carried out restriction endonuclease studies In our original family A, yielding abnonnal DNA patterns of the GH genes. In other Families with IGHD, they found a nonnal pattern.
2) One of our female patients of the same family (26 years, 118 cm) gave birth to a healthy girl (GA 40 weeks, 2370 g, 43 em], GH antibodies were found not only In the mather (12 yea rs after the end of hGH~) but also in the newbom. Five months later, no more ant ibodies were detectable.
3) In another fomily we succeeded for the first time to treat a 5 year-old boy with hGH over a period of 1.5 years without the appearance of HG antibodies 10 for. This is in contrast to his 10 year-old brother previously treated with a different hGH preparat ion who developped high tit.., growth-inhib iting GH antibodies. It appears that certain hGH preparations are tolerated by these potienh who presumably suffer from a prenotol GH deAciency which may cause a lack of immunotolerance for hGH. Supported by the Swiu Notional Science Foundotion Grant No. 3.901.077
